Friday, July 24, 2026 2:27 AM ET
15 hours ago
Eli Lilly says it will file for approval of next-generation obesity drug in 202717 hours ago
Ozempic face? Botox boom boosted by 'sagging face' trend, Swiss firm says18 hours ago
What Trump's generic drug tariffs could mean for patients, drugmakers and prices20 hours ago
RFK Jr. says cyclospora outbreak is 'under control'2 days ago
Cardinal Health's latest deals won't move the needle overnight. They still matter.2 days ago
Novo Nordisk sues Eli Lilly, alleging misleading GLP-1 advertising2 days ago
The FDA made a reversal on cyclosporiasis, but it still thinks iceberg lettuce is to blame2 days ago
What to know about testosterone replacement as U.S. military plans to test troops3 days ago
Market case for psychedelic drugs to treat mental health gets a big buy signal3 days ago
Fat cat? Weight-loss drugs may be coming for your overweight pet6 days ago
Trump rips Canada for wildfire smoke, threatens to raise tariffs6 days ago
Taco Bell says it has removed lettuce linked to cyclosporiasis outbreak from its restaurants6 days ago
World's largest olive oil company says market has 'definitively' entered new phase7 days ago
Buy the contractor before the renovation is complete: This stock's next growth phase is taking shape7 days ago
3 of our stocks rode the AI rally, while 3 others fell out of favor since last month7 days ago
Eli Lilly to buy psychedelics maker AtaiBeckley for $2.8 billion7 days ago
UnitedHealth beats quarterly estimates, hikes profit outlook7 days ago
J&J falls despite a beat-and-raise quarter. Why we're raising our price target anyways8 days ago
Biotech's recovery isn't a 'head fake.' These 3 stocks could lead the next leg up9 days ago
A tiny GLP-1 implant is the latest bet to help patients maintain weight loss9 days ago
AstraZeneca's trial flop raises a bigger question: Is its pipeline premium too vulnerable?12 days ago
Abivax $920 million cash haul lets it prepare for solo U.S. launch instead of relying on a buyer13 days ago
AstraZeneca stock drops after clinical trial miss deals rare blow to pharma powerhouse13 days ago
Employers aren't expanding coverage of GLP-1 obesity drugs, survey says14 days ago
Jim Cramer says these are the 5 stocks to buy during this market rotation17 days ago
Ebola outbreak harder to contain after USAID, Western aid cuts, experts say17 days ago
Jim Cramer says this former Covid market darling is finally investable again22 days ago
Walmart, CVS step in to help seniors with Medicare coverage of obesity drugs22 days ago
FDA lets Philip Morris market Zyn nicotine pouches as less harmful than cigarettes23 days ago
Cramer says this aerospace stock is significantly undervalued, sees 35% upside23 days ago
Medicare will start covering obesity drugs. Here's what patients should know23 days ago